Journal
MOLECULAR THERAPY
Volume 19, Issue 10, Pages 1802-1812Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/mt.2011.147
Keywords
-
Categories
Funding
- Paul Family Gift
- Mayo Foundation
- Cancer Research UK
- NIH [CA107082, CA132734, CA130878]
- Richard Schulze Family Foundation
- Cancer Research UK [10588] Funding Source: researchfish
Ask authors/readers for more resources
We have previously reported that a burst of vascular endothelial growth factor (VEGF) signaling to tumor-associated endothelium induces a proviral state, during which systemically delivered oncolytic reovirus can replicate in endothelium, thereby inducing immune-mediated vascular collapse and significant antitumor therapy. Using chimeric receptors, we show here that induction of the proviral state proceeds through VEGFR2, but not VEGFR1, signaling in endothelial cells. In contrast, innate immune activation by reovirus-exposed endothelial cells was predominantly through VEGFR1. By screening conventional chemotherapies for their ability to induce similar effects in combination with reovirus both in vitro and in vivo, we observed that the proviral state could also be induced in endothelial cells exposed to VEGF during rebound from paclitaxel- mediated inhibition of VEGF signaling. We translated these in vitro findings in vivo by careful scheduling of paclitaxel chemotherapy with systemic virotherapy, neither of which alone had therapeutic effects against B16 tumors. Systemic availability of reovirus during endothelial cell recovery from paclitaxel treatment allowed for endothelial replication of the virus, immune-mediated therapy, and tumor cures. Therefore, careful scheduling of combination viro- and chemotherapies, which preclinical testing suggests are individually ineffective against tumor cells, can lead to rational new clinical protocols for systemic treatments with oncolytic viruses. Received 12 May 2011; accepted 20 June 2011; published online 26 July 2011. doi:10.1038/mt.2011.147
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available